Tag Archives: Only

U.S. only at ‘the beginning of the steep part’ of the coronavirus pandemic, Dr. Scott Gottlieb says

Dr. Scott Gottlieb warned that the United States is only “at the beginning of the steep part of the epidemic” as the number of coronavirus infections and hospitalizations across the country break grim records. In an interview on CNBC’s “The News with Shepard Smith” on Friday, the former FDA chief said, “You’ll see cases start… Read More »

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »

Only Luton, Wolverhampton and the Isles of Scilly saw Covid-19 infection rates drop last week

The red sea of virus: Only Luton, Wolverhampton, and Cornwall and the Isles of Scilly saw Covid-19 infection rates drop last week, Public Health England surveillance report reveals They were the only three regions in England to record a fall in coronavirus cases as it surges elsewhere Wolverhampton was under local lockdown restrictions – with… Read More »

The Only Dryer Sheets You Should Be Using

There’s a rumor going around that fabric-softening dryer sheets contain toxic chemicals that put your health at risk. While Healthline.com pushed back against these claims somewhat, more research is needed to be definite. The largest concern is the fragrances in dryer sheets. A 2011 study published by the Environmental Health Perspectives found that many fragrance… Read More »

FDA Approves Zejula (niraparib) as the Only Once-Daily PARP Inhibitor in First-Line Monotherapy Maintenance Treatment for Women with Platinum-Responsive Advanced Ovarian Cancer Regardless of Biomarker Status

Print this page London UK — 29 April 2020 — Dr. Hal Barron, Chief Scientific Officer and President R&D, GSK, said: “Women with advanced ovarian cancer have a five-year survival rate of less than 50%. This expanded indication means that many more women with this devastating disease can receive earlier treatment with Zejula, which can extend… Read More »

Your only option is to stay home

This is the first time in modern history that humanity is facing a common adversary. As much as Uncle Harry might want to blame the Chinese for this misgiving, it will not change our predicament. The fact is that this time around, our enemy is stealthy, small, and everywhere. We can’t dehumanize, shoot it down,… Read More »